Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcoma

OBJECTIVE: Compare health-related quality of life (HRQoL) of selinexor versus placebo in patients with dedifferentiated liposarcoma. MATERIALS & METHODS: HRQoL was assessed at baseline and day 1 of each cycle using the European Organization for Research and Treatment of Cancer 30-item core quali...

Descripción completa

Detalles Bibliográficos
Autores principales: Gounder, Mrinal, Abdul Razak, Albiruni R, Gilligan, Adrienne M, Leong, Hoyee, Ma, Xiwen, Somaiah, Neeta, Chawla, Sant P, Martin-Broto, Javier, Grignani, Giovanni, Schuetze, Scott M, Vincenzi, Bruno, Wagner, Andrew J, Chmielowski, Bartosz, Jones, Robin L, Shah, Jatin, Shacham, Sharon, Kauffman, Michael, Riedel, Richard F, Attia, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344436/
https://www.ncbi.nlm.nih.gov/pubmed/33855868
http://dx.doi.org/10.2217/fon-2021-0284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344436/
https://www.ncbi.nlm.nih.gov/pubmed/33855868
http://dx.doi.org/10.2217/fon-2021-0284

Ejemplares similares